These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 27206964)
1. High-flow oxygen therapy for treatment of acute migraine: A randomized crossover trial. Singhal AB; Maas MB; Goldstein JN; Mills BB; Chen DW; Ayata C; Kacmarek RM; Topcuoglu MA Cephalalgia; 2017 Jul; 37(8):730-736. PubMed ID: 27206964 [TBL] [Abstract][Full Text] [Related]
2. High-flow oxygen for treatment of cluster headache: a randomized trial. Cohen AS; Burns B; Goadsby PJ JAMA; 2009 Dec; 302(22):2451-7. PubMed ID: 19996400 [TBL] [Abstract][Full Text] [Related]
3. Trans-nasal high-flow dehumidified air in acute migraine headaches: A randomized controlled trial. Shah R; Assis F; Narasimhan B; Khachadourian V; Zhou S; Tandri H; Tariq N Cephalalgia; 2021 Aug; 41(9):968-978. PubMed ID: 33631965 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of high-flow oxygen therapy in all types of headache: a prospective, randomized, placebo-controlled trial. Ozkurt B; Cinar O; Cevik E; Acar AY; Arslan D; Eyi EY; Jay L; Yamanel L; Madsen T Am J Emerg Med; 2012 Nov; 30(9):1760-4. PubMed ID: 22560101 [TBL] [Abstract][Full Text] [Related]
5. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569 [TBL] [Abstract][Full Text] [Related]
6. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group. Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168 [TBL] [Abstract][Full Text] [Related]
9. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks. Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016 [TBL] [Abstract][Full Text] [Related]
10. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine. Cady RK; Goldstein J; Nett R; Mitchell R; Beach ME; Browning R Headache; 2011; 51(7):1078-86. PubMed ID: 21631494 [TBL] [Abstract][Full Text] [Related]
11. A Randomized Trial of Ketorolac vs. Sumatripan vs. Placebo Nasal Spray (KSPN) for Acute Migraine. Rao AS; Gelaye B; Kurth T; Dash PD; Nitchie H; Peterlin BL Headache; 2016 Feb; 56(2):331-40. PubMed ID: 26840902 [TBL] [Abstract][Full Text] [Related]
12. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study. Bell CF; Foley KA; Barlas S; Solomon G; Hu XH Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170 [TBL] [Abstract][Full Text] [Related]
13. Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS Study. Lipton RB; McGinley JS; Shulman KJ; Wirth RJ; Buse DC Headache; 2017 Nov; 57(10):1570-1582. PubMed ID: 28880380 [TBL] [Abstract][Full Text] [Related]
14. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814 [TBL] [Abstract][Full Text] [Related]
15. Oxygen treatment for cluster headache attacks at different flow rates: a double-blind, randomized, crossover study. Dirkx THT; Haane DYP; Koehler PJ J Headache Pain; 2018 Oct; 19(1):94. PubMed ID: 30306284 [TBL] [Abstract][Full Text] [Related]
16. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF; Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038 [TBL] [Abstract][Full Text] [Related]
17. Kinetic oscillation stimulation as treatment of acute migraine: a randomized, controlled pilot study. Juto JE; Hallin RG Headache; 2015 Jan; 55(1):117-27. PubMed ID: 25546476 [TBL] [Abstract][Full Text] [Related]
18. Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it? Calhoun AH; Ford S Postgrad Med; 2014 Mar; 126(2):86-90. PubMed ID: 24685971 [TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults. Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463 [TBL] [Abstract][Full Text] [Related]
20. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study. Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]